<DOC>
	<DOCNO>NCT00247299</DOCNO>
	<brief_summary>The Intense Pulsed Light ( IPL ) technology , selective phototermolysis , use eliminating , among application , benign vascular lesion unwanted leg vein . Light energy heat deeper structure skin . IPL device provide broad wavelength spectrum 515 1200 nm fluence 10 40 J/cm o.5-1 Hz.The light focus reflector transmit various filter cut low wavelength range emit light ; therefore , wavelength long filter transmit . objective : 1. evaluate optimize clinical performance Luminis ONE platform aforementioned clinical application . 2 . Reconfirm parameter setting aforementioned clinical application . 3 . Confirm user friendly design device , aspect software ( user interface ) various technical operational feature .</brief_summary>
	<brief_title>Evaluation Optimization Technical Clinical Performance Lumenis ONE Platform</brief_title>
	<detailed_description>Background : The Intense Pulsed Light ( IPL ) technology , selective phototermolysis , use eliminating , among application , benign vascular lesion unwanted leg vein . Light energy heat deeper structure skin . IPL device provide broad wavelength spectrum 515 1200 nm fluence 10 40 J/cm o.5-1 Hz.The light focus reflector transmit various filter cut low wavelength range emit light ; therefore , wavelegths long filter transmit . Material Methods : The luminis ONE medical system ( Lumenis Ltd. , Yokneam , Israel , Pleasanton , CA , USA ) incorporate non coherent pulse light head . Vascular lesion Telangiectases , leg vein PWS treat IPL , follow filter :515,50 , 590 . Following every treatment subject ask much pain felt , use score 1-5 . Photographs take treatment . Every subject treat 5 treatment , 5+1 week interval . clearance improvement evaluate physician visit , next treatment use follow scale : 1 . No clearance 2 . 0-25 % 3 . 25-50 % 4 . 50-75 % 5 . 75-100 %</detailed_description>
	<mesh_term>Port-Wine Stain</mesh_term>
	<mesh_term>Hemangioma , Capillary</mesh_term>
	<mesh_term>Telangiectasis</mesh_term>
	<criteria>Healthy Subjects , present least one clinical indication mention Willing able comply visit evaluation requirement Willing able provide sign Informed Consent A history keloid scar formation poor wound heal Wounded tan area treat Pregnant intend become pregnant evaluation period Subjects bleeding disorder take anticoagulation medication Significant concurrent illness , diabetes , epilepsy , lupus congestive heart failure Significant concurrent skin condition affect area treat Having history skin cancer cancer area treat History immunosuppressive disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2005</verification_date>
	<keyword>Vascular lesion</keyword>
	<keyword>Intense pulse light</keyword>
	<keyword>phototermolysis</keyword>
	<keyword>wavelength</keyword>
	<keyword>filter</keyword>
	<keyword>non coherent</keyword>
</DOC>